RxDoctor Payments Data

Ghadir Salame, MD

Gynecologic Oncology · Brooklyn, NYNPI 1144517921

Payments from drug & device makers

What this record shows

This record is dominated by education: $164,000 of the $179,187 with a category attached, or 91.5%. Intuitive Surgical accounts for 98.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $63,181 and has fallen 84.7% since, to $9,696 in 2025. Among gynecologic oncology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$179,187in general payments, 2019–2025

Across 161 payments — averaging $1112.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$177K
  • Virtual Incision Corporation$1K
  • GSK$171
  • Dilon Technologies, Inc.$158
  • Merck$145
  • Johnson & Johnson$80
  • plus $167 from 5 others

What the payments were for

  • Travel & lodging$4,1982%
  • Food & beverage$10,9656%
  • Education$164,00092%
  • Gifts$240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$179,187 in reported general payments places this provider in the 95th percentile of 154 gynecologic oncology providers in New York.

See all gynecologic oncology providers in New York

Medicare billing

Part B allowed, 2024
$41,847
Medicare patients
53
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →